Better Health, Brighter Future
Retail Investor Resource Hub
Takeda Stories
Investor Events
Check back for event calendar updates or sign up for email alerts straight to your inbox.
Featured
Takeda has published its 2022 Annual Integrated Report
Find out how our financial and other impacts are creating value in the short, medium and long term, and the focus areas we believe are most important for the stakeholders and communities we serve. READ MORE
Innovation at Takeda
Our world-class R&D engine is focused on developing medicines and vaccines that will have a lasting impact on society and can make a critical difference to the lives of patients with limited or no options for treatment.
Frequently Asked Questions
General Information
Our 146th Ordinary General Meeting of Shareholders was held on June 29, 2022. Please visit our Annual Shareholders Meeting page for more information.
You may contact a licensed stockbroker or go through any registered broker-dealer to purchase shares of Takeda.
Takeda’s common shares are traded on the Tokyo Stock Exchange using stock code “4502.” Our ADSs are traded on the New York Stock Exchange using the symbol “TAK”.
An American Depositary Receipt (ADR) is a certificate representing ownership of American Depositary Shares (ADSs) in a non-U.S. corporation. They include the right to attend and vote at AGMs, the receipt of dividends, and other common shareholder rights. One ADS represents 0.5 shares of Takeda’s common stock.
Click here to learn more about Takeda’s historic share price performance.
Dividend Information
Takeda has maintained a well-established dividend policy of 180 yen per share annually. Information on historical dividends paid by Takeda can be found here
Takeda’s dividend payments have historically been issued on a semi-annual basis in June and December. The record date for year-end dividends is March 31 of each year. The record date for interim dividends is September 30 of each year.
Financial Information
Takeda’s fiscal year ends on March 31st. You can find our earnings materials and dates on our financial results webpage.
Takeda’s official reporting currency is the yen.
Takeda follows the International Financial Reporting Standards, or IFRS, for its financial reporting.
For historic financial highlights of Takeda, please refer to our Financial Highlights page.
Additional Information
To send a comment or question to Takeda Pharmaceutical Company Limited, please visit: https://www.takeda.com/who-we-are/contact-us/
To subscribe to email alerts from Takeda, please use the form at the top of this page.
For feedback or inquiries, please visit https://www.takeda.com/who-we-are/contact-us/